Actively Recruiting

Phase 3
Age: 20Years +
All Genders
NCT05766592

Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents

Led by Yale University · Updated on 2026-01-13

124

Participants Needed

2

Research Sites

150 weeks

Total Duration

On this page

Sponsors

Y

Yale University

Lead Sponsor

B

Ben-Gurion University of the Negev

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms. The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms (e.g., rejection sensitivity, internalized stigma, emotion dysregulation, parental rejection and acceptance).

CONDITIONS

Official Title

Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 20 years old or older
  • Be fluent in English
  • Self-identify as lesbian, bisexual, queer, pansexual, or another non-heterosexual identity
  • Currently have elevated depressive or anxiety symptoms
  • Report at least moderate parental rejection or low parental acceptance
  • Have at least one rejecting or nonaccepting parent who agrees to participate in therapy
  • Live in New York State, Pennsylvania, Connecticut, or Israel
Not Eligible

You will not qualify if you...

  • Receiving current mental health treatment one day or more per month (except medication management up to one day per week)
  • Started new medication within the past 30 days
  • Experiencing active psychosis or mania
  • Experiencing active suicidality or homicidality
  • Legally required to attend treatment
  • Have significant cognitive impairment
  • Do not have a parent willing to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Yale LGBTQ Mental Health Initiative with the Yale School of Public Health Office

New York, New York, United States, 10001

Not Yet Recruiting

2

Ben-Gurion University Psychotherapy Research Lab

Beersheba, Israel, 84105

Actively Recruiting

Loading map...

Research Team

J

John E Pachankis, PhD

CONTACT

D

Danielle M Chiaramonte, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here